Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma
Yannis Metaxas, Gareth Rivalland(Olivia Newton-John Cancer Wellness & Research Centre), Laetitia Mauti(Kantonsspital Winterthur), Dirk Klingbiel(University of Bern), Steven Kao(Chris O’Brien Lifehouse), Sabine Schmid(University of Bern), Anna K. Nowak(The University of Western Australia), Oliver Gautschi(University of Lucerne), T. Bartnick(Kantonsspital Baden), Brett Hughes(Royal Brisbane and Women's Hospital), Hasna Bouchaab(University of Lausanne), Sacha I. Rothschild(University Hospital of Basel), Nick Pavlakis(The University of Sydney), Sibylle Wolleb(Spital Uster), Ulf Petrausch(Center for Pediatric Endocrinology Zurich), Kenneth J. O’Byrne(Queensland University of Technology), Patrizia Froesch(Scuola Cantonale di Commercio Bellinzona), Melanie Löffler-Baumann(St. Claraspital), Susanne Pratsch-Peter(Stadtspital Waid), Prudence A. Russell(St Vincent's Hospital Melbourne), Walter Mingrone(Solothurner Spitäler), Spasenija Savic(University Hospital of Basel), Bibhusal Thapa(Olivia Newton-John Cancer Wellness & Research Centre), Martin Früh(University of Bern), Miklos Pless(Kantonsspital Winterthur), Roger von Moos, Thomas John(Olivia Newton-John Cancer Wellness & Research Centre)
Cited by 91Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis